Characteristics of thawed autologous umbilical cord blood

Transfusion

Volumn 52, Issue 10, 2012, Pages 2234-2242

  Rosenau, Emma H ^a   Sugrue, Michele W ^a   Haller, Michael ^a   Fisk, Diann ^a   Kelly, Susan S ^a   Chang, Myron ^a   Hou, Wei ^a   Eldjerou, Lamis ^a   Slayton, William ^a   Cogle, Christopher R ^a   Wingard, John R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ARTICLE; AUTOLOGOUS UMBILICAL CORD BLOOD; CELL COUNT; CELL VIABILITY; CHILD; COLONY FORMING UNIT GM; CRYOPRESERVATION; FREEZE THAWING; HUMAN; OPEN STUDY; PHASE 1 CLINICAL TRIAL; PRESCHOOL CHILD; PROCESS DESIGN; SCHOOL CHILD; SHELF LIFE; TOTAL NUCLEATED CELL; UMBILICAL CORD BLOOD;

BACTERIOLOGICAL TECHNIQUES; BLOOD BANKS; BLOOD CELL COUNT; BLOOD CELLS; BLOOD PRESERVATION; BLOOD TRANSFUSION, AUTOLOGOUS; CELL SURVIVAL; CLINICAL TRIALS, PHASE I AS TOPIC; COLONY-FORMING UNITS ASSAY; CRYOPRESERVATION; DIABETES MELLITUS, TYPE 1; FETAL BLOOD; HUMANS; STAINING AND LABELING;

EID: 84868300134     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03556.x     Document Type: Article

References (19)

1. Ballen K,. Challenges in umbilical cord blood stem cell banking for stem cell reviews and reports. Stem Cell Rev 2010; 6: 8-14.
2. Hollands P, McCauley C,. Private cord blood banking: current use and clinical future. Stem Cell Rev 2009; 5: 195-203.
3. Thornley I, Eapen M, Sung L, Lee S, Davies S, Joffe S,. Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. Pediatrics 2009; 123: 1011-7.
4. Guidance for Industry. Minimally manipulated, unrelated allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution for specific indications. October 2009. [cited 2009 Nov 1]. Available from: URL: http://www.fda.gov/downloads/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM187144.pdf
5. Querol S, Gomez S, Pagliuca A, Torrabadella M, Madrigal J,. Quality rather than quantity: the cord blood bank dilemma. Bone Marrow Transplant 2010; 45: 970-8.
6. Rubinstein P,. Cord blood banking for clinical transplantation. Bone Marrow Transplant 2009; 44: 635-42.
7. Berz D, McCormack E, Winer E, Colvin G, Quesenberry P,. Cryopreservation of hematopoietic stem cells. Am J Hematol 2007; 82: 463-72.
8. George T, Sugrue M, George S, Wingard J,. Factors associated with parameters of engraftment potential of umbilical cord blood. Transfusion 2006; 46: 1803-12.
9. Wagner E, Duval M, Dalle J, Morin H, Bizier S, Champagne J, Champagne MA,. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion 2006; 46: 1190-8.
10. Sun J, Allison J, McLaughlin C, Sledge L, Waters-Pick B, Wease S, Kurtzberg J,. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion 2010; 50: 1980-7.
11. Haller M, Wasserfall C, McGrail K, Cintron M, Brusko TM, Wingard JR, Kelly SS, Shuster JJ, Atkinson MA, Schatz DA,. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 2009; 32: 2041-6.
12. Fraser J, Cairo M, Wagner E, McCurdy PR, Baxter-Lowe LA, Carter SL, Kernan NA, Lill MC, Slone V, Wagner JE, Wallas CH, Kurtzberg J,. Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother 1998; 7: 521-61.
13. Cord Blood Transplantation Study (COBLT), Rockville, MD. Cord blood bank standard operating procedures. Carolinas Cord Blood Bank-Duke University & University of California-Los Angeles Cord Blood Bank. 2003. [cited 2005 Oct 1]. Available from: URL: https://web.emmes.com/study/cord/sop.htm
14. Hübl W, Iturraspe J, Martinez G, Hutcheson CE, Roberts CG, Fisk DD, Sugrue MW, Wingard JR, Braylan RC,. Measurement of absolute concentration and viability of CD34+ cells in cord blood and cord blood products using fluorescent beads and cyanine nucleic acid dyes. Cytometry 1998; 34: 121-7.
15. US Department of Health and Human Services. Contract between the Health Resources and Services Administration and the LifeCord Cord Blood Bank, contract #HHSH 234200867003C, September. 2008.
16. Barker JN, Byam C, Scaradavou A,. How I treat: the selection and acquisition of unrelated cord blood grafts. Blood 2011; 117: 2332-9.
17. NMDP RE,. BB-IND#7555: A centralized cord blood registry to facilitate allogeneic, unrelated umbilical cord blood transplantation. Investigation Outcome Letter 6/29/2010. 2010. [cited 2011 Aug 1]. http://cblworkshop.transtem. com/dotnetnuke/LinkClick.aspx?fileticket=fLzQnubecpM%3D&tabid=121&mid= 476
18. Regan D, Wofford JD, Wall DA,. Comparison of cord blood thawing methods on cell recovery, potency, and infusion. Transfusion 2010; 50: 2670-5.
19. American Association of Blood Banks. Standards for Cellular Therapy Product Services, 4th ed. Bethesda, MD: American Association of Blood Banks; 2009.